Raltegravir asks two things of you: reasonably even spacing if you are on the twice-daily formulation, and keeping antacids away from it.
What is the schedule?
Twice daily, roughly twelve hours apart, for the 400mg tablets. Once daily for the 1200mg formulation taken as two 600mg tablets. Follow the schedule for the strength you have been given rather than a general rule.
Does the spacing need to be exact?
Roughly even is enough. Morning and evening at times you will actually keep to works better than an exact twelve-hour interval you cannot sustain. Consistency matters more than precision.
With or without food?
Either. Raltegravir has no food requirement, which is one of the things that makes it straightforward. If your backbone has one, follow that instruction for the tablet it applies to.
What is the antacid problem?
Raltegravir binds to metal ions. Antacids containing aluminium or magnesium reduce its levels substantially and are generally not recommended alongside it at all, rather than merely needing spacing.
What about calcium and iron?
Calcium carbonate antacids can be taken with the twice-daily formulation, and are not recommended with the once-daily one. Iron and multivitamins need spacing. Ask for specific instructions for your formulation rather than estimating.
Why is that more complicated than with other integrase inhibitors?
Because the two formulations behave differently, so advice that applies to one does not always apply to the other. If you are unsure, a clinic pharmacist will tell you in a minute.
How long does it take to work?
Rapidly. Raltegravir reduces viral load quickly, which is one reason it is used when someone presents late in pregnancy. Suppression is usually established within one to six months depending on the starting level.
What if you miss a dose?
Take it as soon as you remember unless it is nearly time for the next, in which case skip it rather than doubling up. With twice-daily dosing, missing one is more consequential than on a once-daily regimen.
Why does that matter more here?
Because the resistance barrier is lower than dolutegravir's, and because two doses a day means twice as many opportunities to forget. A pattern of missed doses is worth addressing sooner rather than later.
What if twice daily does not suit you?
Say so. The once-daily formulation exists for exactly that reason, and switching between formulations is a prescribing decision that is easy to make once the problem is known.
What if you vomit after taking it?
If within an hour, take another. Beyond that it has generally been absorbed. Recurrent vomiting warrants a call to the clinic rather than repeated guessing.
Can you stop it?
Not independently. Stopping allows the virus to rebound within weeks and restores transmission risk. Where a change is needed it is made by switching rather than stopping.
What about your backbone?
If it contains lamivudine, emtricitabine or tenofovir, stopping also risks a hepatitis B flare in anyone with chronic infection. That is a further reason any change needs planning.
What about travel?
Keep to the same clock times in the new zone and accept one short or long interval. Twice-daily dosing is harder across time zones, so it is worth thinking through before a long trip.
What if you keep forgetting?
Say so rather than treating it as a personal failing. Alarms, organisers and the once-daily formulation are all options, and clinics deal with this constantly.